This review provides an overview of the recent literature on application of arylglyoxals the synthesis of pyrrolo [2,3-d] 
Introduction
There is a worldwide demand for design and preparation of heterocyclic compounds by reactions with more than two components, by forming more than one carbon-carbon or carbon-heteroatom bond by environmentally and economically useful one-pot procedures, usually referred to as multicomponent reactions (MCRs). These have been proved to be powerful synthetic methods for the synthesis of polycyclic heterocycles with pharmaceutical and biological activities [1] [2] [3] [4] [5] [6] [7] . More than 70% of drugs in common use are now synthetic heterocyclic compounds [8] [9] [10] [11] [12] . MCRs have many advantages in comparison with classical reactions, such as fewer isolation and purification steps, with high atom-economy, low cost and energy consumption, short reaction time, using green solvents, high selectivity, environmentally friendly chemical processes, easy operation and more productivity with excellent chemo-and regioselectivities [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . 1,2-Dicarbonyl compounds are among the most attractive precursors for the design and synthesis of heterocyclic compounds. Arylglyoxals (AG) are aromatic α-keto aldehydes containing both aldehyde and ketone functional groups with different reactivity, and recently there has been a considerable literature on different reactions of AGs and their derivatives, such as allylation [24] , arylation [25] , reductive amination [23] , reductive coupling with dienes [27] , Wittig [28] , Cannizzaro [29] , Mannich [30] and Henry [31] reactions. The main purpose of this short review is to show the application of AGs as precursors in reactions that lead to the synthesis of the pyrrolo [2,3-d] pyrimidine derivatives via multicomponent reactions in the period of 2008-2018.
Recently, fused-pyrimidine derivatives have received considerable attention due to their biological and pharmacological activities such as anti-AIDS [32] , antifungal [33] , antileishmanial [34] , tuberculostatic [35] , antimicrobial [36] , antitumor [37] , sedative [38] , anti-inflammatory [39] , antioxidant [40] , analgesic [41] antiviral [42] anesthetic [43] , acaricidal [44] , anticancer [42] , and antifolate [43] . These compounds are present in nucleosides such as pyrimidines, cytosine, uracil, guanine, thymine and purine adenine and their respective polymers, DNA and RNA [45, 48] .
Scheme 1. Structures of few medicinally heterocyclic fused pyrimidines
As the natural bases do not have any fluorescence, several groups have been attached or the base itself has been modified [49, 50] . Although these heterocyclic compounds have been known since the middle of the twentieth century [51, 52] , they were not extensively studied until the last few decades. More recently, the interest of the chemical and pharmaceutical industry in heterocyclic fused pyrimidines, also named deazapurines, has increased notably, resulting in a large increase in the number of patents, research papers, and reviews, all of which led to the introduction of several drugs in the market or late clinical stages (Scheme 1) [53] [54] .
Arylglyoxals
Phenylglyoxal (PG), the simplest member of this family, is a yellow liquid that polymerizes upon standing. Upon heating, it loses a molecule of water and the polymeric material changes to the aldehyde form or anhydrous AG. To form the colorless crystalline hydrate, PG should be recrystallized in hot water. The AG-hydrate appears to contain one molecule of water (Scheme 2).
Scheme 2. Structures of Arylglyoxals
AGs contain aldehyde and ketone functional groups with different reactivity, the reactivity of the aldehyde group is greater than that of benzaldehyde because of the electron-withdrawing keto group and reacts quickly with different nucleophiles, the resulting product then undergoing cyclization in a number of ways. The resulting products have received considerable attention due to their biological and pharmacological activities, such as selective bronchodilators such as salbutamol and terbutaline, used for their selective and antiviral activity in the embryonated egg against several viruses, including influenza (PR-8) and newcastle disease (NJKD strain) viruses [55] [56] [57] . Dommaraju and coworkers developed a methodology based on a two-step sequence using 4-methoxy-aniline 16, 1,3-dimethyl barbituric acid 7 and 4-methyl phenylglyoxal 1 with 1,3-indanedione 17 or dimedone 2 or 2-hydroxy-1,4-naphtaquinone 18 or 6-aminouracil 3 in equimolar quantities into a one-pot reaction in ethanol (Scheme 8) [80] . Naidu and co-workers reported the use of microwave irradiation for the three component reaction of N,Ndimethyl-6-aminouracil 3, phenylglyoxal 1, and aniline 16 at 100 o C for 5 min, achieving an excellent yield of 84% when acetic acid was used as a solvent, without any added catalyst (Scheme 9) [81] . Khalafy and coworkers used TPAB as catalyst in the reaction between 1,4-phenylene-bis-glyoxal 35, 6-aminouracil derivatives 3, and barbituric acid derivatives 5 or dimedone 2 in a one-pot, threecomponent reaction in EtOH under reflux conditions for the synthesis of bis-pyrrolo [2,3-d] pyrimidine derivatives 36 and 37 in high yields (Scheme 17) [89] . 
Conclusion
This study presented an overview of the recent literature on application of the arylglyoxals for synthesis of the pyrrolo [2,3-d] 
